Prm124 - Modelling Likely Cardiovascular Disease Mortality With Pcsk9 Inhibitors Using a Synthetic Population

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2244
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

PCSK9 Peptide Inhibitors

Science-Business eXchange
2014English

Mortality From Cardiovascular Disease

Health at a Glance: Asia/Pacific
2018English

Association of Peripheral Arterial Disease With All-Cause Mortality, Cardiovascular Mortality and Cardiovascular Events

Angiology: Open Access
2013English

Modelling the Impact of Compliance With Dietary Recommendations on Cancer and Cardiovascular Disease Mortality in Canada

Public Health
MedicineEnvironmentalPublic HealthOccupational Health
2014English

PCSK9 as Predictor for Recurrent Cardiovascular Disease in Familial Hypercholesterolemia

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2019English

PCSK9 Inhibitors: A Technology Worth Paying For?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2015English

Are PCSK9 Inhibitors Cost Effective?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2018English

A Prospective Population-Based Cohort Study of Lactation and Cardiovascular Disease Mortality: The HUNT Study

BMC Public Health
EnvironmentalPublic HealthOccupational Health
2013English

PCSK9 Inhibitors: When Statins Aren't Enough

Prescriber
Pharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy